Table 1.
Acute mountain sickness and headache
AMS– (n= 9) | AMS+ (n= 9) | ||||||
---|---|---|---|---|---|---|---|
GROUP: | |||||||
CONDITION: | Normoxia | Hypoxia | Δ | Normoxia | Hypoxia | Δ | |
LL (points) | 0 ± 1 | 4 ± 2 | 3 ± 2 | 1 ± 1 | 8 ± 3*† | 8 ± 3† | Group and condition main effects/Group × Condition interaction |
ESQ-C (AU) | 0.0 ± 0.0 | 0.4 ± 0.2* | 0.3 ± 0.2 | 0.0 ± 0.0 | 2.0 ± 1.3*† | 2.0 ± 1.3† | Group and condition main effects/Group × Condition interaction |
VAS (mm) | 1 ± 2 | 6 ± 9 | 6 ± 8 | 0 ± 0 | 47 ± 27*† | 47 ± 27† | Group and condition main effects/Group × Condition interaction |
Values are mean ±s.d.; AMS–, subjects without (AMS–) and with (AMS+) acute mountain sickness; main effect for group indicates a pooled (normoxia + hypoxia) difference (P < 0.05) between AMS–versus AMS+; main effect for condition indicates a pooled (AMS–+ AMS+) difference (P < 0.05) between normoxia versus hypoxia;
different within and
between groups (P < 0.05); LL, Lake Louise score; ESQ-C, Environmental Symptoms Questionnaire Cerebral Symptoms score in arbitrary units (AU); VAS, Visual Analogue Scale score; Δ, delta value (hypoxia minus normoxia).